In 2021, evolving market conditions, including heightened regulatory risk, emergence of new theories of harm, and the continuing economic impact of COVID-19 could alter transaction dynamics and contribute to more – and more contentious – transaction-related antitrust litigation, both with authorities and between merging parties.

In our 11th episode, Jenn Mellott speaks with Linda Martin, Martin Klusmann and Nicholas Frey about how companies can mitigate litigation risk in their transactions with the right transactional toolkit.